MAIA Stock Analysis: Buy, Sell, or Hold?
MAIA - MAIA Biotechnology, Inc.
$1.33
-0.01 (-0.75%)
▼
5d:
-3.62%
30d:
-14.74%
90d:
-13.07%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 08, 2026
Get Alerted When MAIA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MAIA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: MAIA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1.89
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$1.17
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 0.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MAIA is currently trading at $1.33, which is considered slightly low relative to its 30-day fair value range of $1.33 to $1.99. The stock's valuation (Forward PE: 0.5) is in line with its historical norms (0.5). Remarkably, the market is currently pricing in an annual earnings decline of 1.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, MAIA is in a strong downtrend. Immediate support is located at $1.27, while resistance sits at $1.51.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.13 (+812.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MAIA is in a strong downtrend. Immediate support is located at $1.27, while resistance sits at $1.51.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.13 (+812.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$1.33 -
$1.99
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 812.4% below Wall St target ($12.13)
Fair Price Analysis
30-Day Fair Range
$1.33 -
$1.99
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.27
Resistance Level
$1.51
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.49
Wall Street Target
$12.14
(+812.4%)
Valuation Discount vs History
-1.1% cheaper
PE vs Historical
0.5 vs 0.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.1%
(market-implied from PE analysis)
1-Year Target
$1.32
(-1%)
2-Year Target
$1.30
(-2%)
3-Year Target
$1.29
(-3%)
3-Yr Target (if PE normalizes)
(PE: 0→1)
$1.31
(-2%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.5 to 0.5
Stabilization Target:
$1.35
(+1.5%)
PE Expansion Potential:
+1.5%
Share & Embed Analysis
Last updated: April 03, 2026 11:41 PM ET
Data refreshes hourly during market hours. Next update: 12:41 AM
Data refreshes hourly during market hours. Next update: 12:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MAIA showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 53 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 67 BUY |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$33 | 61 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$43 | 65 BUY |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 58 HOLD |
